Constructing inverse probability weights for marginal structural models
- PMID: 18682488
- PMCID: PMC2732954
- DOI: 10.1093/aje/kwn164
Constructing inverse probability weights for marginal structural models
Abstract
The method of inverse probability weighting (henceforth, weighting) can be used to adjust for measured confounding and selection bias under the four assumptions of consistency, exchangeability, positivity, and no misspecification of the model used to estimate weights. In recent years, several published estimates of the effect of time-varying exposures have been based on weighted estimation of the parameters of marginal structural models because, unlike standard statistical methods, weighting can appropriately adjust for measured time-varying confounders affected by prior exposure. As an example, the authors describe the last three assumptions using the change in viral load due to initiation of antiretroviral therapy among 918 human immunodeficiency virus-infected US men and women followed for a median of 5.8 years between 1996 and 2005. The authors describe possible tradeoffs that an epidemiologist may encounter when attempting to make inferences. For instance, a tradeoff between bias and precision is illustrated as a function of the extent to which confounding is controlled. Weight truncation is presented as an informal and easily implemented method to deal with these tradeoffs. Inverse probability weighting provides a powerful methodological tool that may uncover causal effects of exposures that are otherwise obscured. However, as with all methods, diagnostics and sensitivity analyses are essential for proper use.
Similar articles
-
Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.Am J Epidemiol. 2010 Jan 1;171(1):113-22. doi: 10.1093/aje/kwp329. Epub 2009 Nov 24. Am J Epidemiol. 2010. PMID: 19934191 Free PMC article.
-
Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.Am J Epidemiol. 2012 Mar 1;175(5):381-90. doi: 10.1093/aje/kwr346. Epub 2012 Feb 1. Am J Epidemiol. 2012. PMID: 22302074 Free PMC article.
-
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.Am J Epidemiol. 2003 Oct 1;158(7):687-94. doi: 10.1093/aje/kwg206. Am J Epidemiol. 2003. PMID: 14507605
-
Comparison of dynamic treatment regimes via inverse probability weighting.Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):237-42. doi: 10.1111/j.1742-7843.2006.pto_329.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16611197 Review.
-
Structural equation modeling versus marginal structural modeling for assessing mediation in the presence of posttreatment confounding.Psychol Methods. 2015 Jun;20(2):204-20. doi: 10.1037/a0036368. Epub 2015 Mar 9. Psychol Methods. 2015. PMID: 25751514 Review.
Cited by 674 articles
-
Causal Mediation Analysis in the Presence of Post-treatment Confounding Variables: A Monte Carlo Simulation Study.Front Psychol. 2020 Aug 14;11:2067. doi: 10.3389/fpsyg.2020.02067. eCollection 2020. Front Psychol. 2020. PMID: 32922345 Free PMC article.
-
Unmet social needs among low-income adults in the United States: Associations with health care access and quality.Health Serv Res. 2020 Oct;55 Suppl 2(Suppl 2):873-882. doi: 10.1111/1475-6773.13555. Epub 2020 Sep 3. Health Serv Res. 2020. PMID: 32880945 Free PMC article.
-
Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.JAMA Psychiatry. 2020 Sep 2:e202762. doi: 10.1001/jamapsychiatry.2020.2762. Online ahead of print. JAMA Psychiatry. 2020. PMID: 32876659
-
Estimating the Effect of Depression on HIV Transmission Risk Behaviors Among People Who Inject Drugs in Vietnam: A Causal Approach.AIDS Behav. 2020 Aug 24:1-9. doi: 10.1007/s10461-020-03007-9. Online ahead of print. AIDS Behav. 2020. PMID: 32833193 Free PMC article.
-
Effect of renal support therapy on 5-year survival in patients discharged from the intensive care unit.J Intensive Care. 2020 Aug 18;8:63. doi: 10.1186/s40560-020-00481-0. eCollection 2020. J Intensive Care. 2020. PMID: 32832092 Free PMC article.
Publication types
MeSH terms
Grant support
- U01 AI035042/AI/NIAID NIH HHS/United States
- R01-AI073127/AI/NIAID NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 HD032632-14/HD/NICHD NIH HHS/United States
- U01 AI035004-11S2/AI/NIAID NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- UO1-AI-37984/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- U01 AI037984-08/AI/NIAID NIH HHS/United States
- U01 AI035040-16/AI/NIAID NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- R03 AI071763/AI/NIAID NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R01 AI073127-02/AI/NIAID NIH HHS/United States
- R03-AI071763/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01 AI034994-15/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- AI-34989/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01 AI042590-12/AI/NIAID NIH HHS/United States
- U01 AI034989-15/AI/NIAID NIH HHS/United States
- U01 AI035043-16/AI/NIAID NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01 AI035041-16/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI031834-16/AI/NIAID NIH HHS/United States
- U01 AI035042-16/AI/NIAID NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI037613-08/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- 5-MO1-RR-00722/RR/NCRR NIH HHS/United States
- U01 AI035039-16/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01 AI034993-15/AI/NIAID NIH HHS/United States
- R01 AI073127/AI/NIAID NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- UO1-AI-37613/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
